Predict your next investment

Venture Capital
innocap-goettingen.de

See what CB Insights has to offer

Investments

5

Funds

1

About InnoCap

Provider of Internet incubator services focusing on the life sciences. Mediport Venture established this fund with the University of Goettingen (Germany) and regional business partners This fund with a volume of 7.5 million € provides seed funding for spin-offs from the University of Goettingen and other institutions in the region.

InnoCap Headquarter Location

Kaete-Hamburger-Weg 6

Gottingen, 37073,

Germany

49 551397953

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest InnoCap News

Innocap, Inc. Secures Major Shipping Contract by Air

Dec 2, 2020

Innocap, Inc. Secures Major Shipping Contract by Air Innocap, Inc. Secures Major Shipping Contract by Air Share Last updated Dec 2, 2020 NEW YORK, Dec. 2, 2020 /PRNewswire/ — Innocap, Inc. (“INNO” or the “Company”), a global logistics and freight forwarding company, today announced that it had secured multiple contracts for bulk air shipments of retail products from Asia to the United States. INNO has already operated 47…

InnoCap Investments

5 Investments

InnoCap has made 5 investments. Their latest investment was in Avontec as part of their Series B on August 8, 2005.

CBI Logo

InnoCap Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/10/2005

Series B

Avontec

$17.83M

No

BioMedPartners, Deutsche Venture Capital, Mediport, and Undisclosed Investors

1

11/1/2002

Seed

Subscribe to see more

$99M

Subscribe to see more

10

8/31/2002

Series A

Subscribe to see more

$99M

Subscribe to see more

10

8/15/2002

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

6/1/2001

Convertible Note

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/10/2005

11/1/2002

8/31/2002

8/15/2002

6/1/2001

Round

Series B

Seed

Series A

Seed VC

Convertible Note

Company

Avontec

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$17.83M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

BioMedPartners, Deutsche Venture Capital, Mediport, and Undisclosed Investors

Sources

1

10

10

10

10

InnoCap Fund History

1 Fund History

InnoCap has 1 fund, including Innovations-Capital Gottingen.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/1/2001

Innovations-Capital Gottingen

Early-Stage Venture Capital

$7.14M

1

Closing Date

4/1/2001

Fund

Innovations-Capital Gottingen

Fund Type

Early-Stage Venture Capital

Status

Amount

$7.14M

Sources

1

InnoCap Team

3 Team Members

InnoCap has 3 team members, including current Managing Director, Matthias Faensen.

Name

Work History

Title

Status

Matthias Faensen

Managing Director

Current

Stefan Keveloh

Managing Director

Current

Alexander Bertram-Drogatz

Mediport, and Ganomycin

Managing Director

Former

Name

Matthias Faensen

Stefan Keveloh

Alexander Bertram-Drogatz

Work History

Mediport, and Ganomycin

Title

Managing Director

Managing Director

Managing Director

Status

Current

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.